FDA procedurally removed it from Category 2 in April 2026 after nominators withdrew their submissions and referred it to the Pharmacy Compounding Advisory Committee, which is scheduled to review it on July 23-24, 2026 for possible inclusion on the approved 503A bulks list
By understanding the genetic factors that contribute to acne severity and treatment responses, clinicians may offer more personalized, effective, and safer treatment options
As with any active ingredient, it is best to follow usage instructions and monitor how your scalp responds
Every 5-Amino-1MQ plan starts with comprehensive labs, a physician-supervised protocol built around your goals, medical-grade sourcing, and ongoing monitoring paired with our broader peptide protocols and metabolic care where it makes sense
After a B12 injection, avoid strenuous activity for 24 hours, refrain from soaking in hot baths or jacuzzis for at least 24 hours, and do not rub the injection site
Research-only status: Since DSIP is not FDA-approved, all current dosing practices remain experimental